| 0 |
Complement Inhibitor [EPC] |
26 |
0.0005 |
| 1 |
Neonatal Fc Receptor Blocker [EPC] |
1 |
0.0002 |
| 2 |
B Lymphocyte Stimulator-specific Inhibitor [EPC] |
6 |
0.0002 |
| 3 |
Alkaloid [EPC] |
3 |
0.0001 |
| 4 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
7 |
0.0001 |
| 5 |
Anticholinergic [EPC] |
1 |
0.0001 |
| 6 |
Carbonic Anhydrase Inhibitor [EPC] |
1 |
0.0000 |
| 7 |
Antimetabolite Immunosuppressant [EPC] |
1 |
0.0000 |
| 8 |
Tetracycline-class Drug [EPC] |
3 |
0.0000 |
| 9 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
2 |
0.0000 |
| 10 |
Androgen [EPC] |
1 |
0.0000 |
| 11 |
Provitamin D2 Compound [EPC] |
1 |
0.0000 |
| 12 |
Glycopeptide Antibacterial [EPC] |
2 |
0.0000 |
| 13 |
Cholinergic Muscarinic Antagonist [EPC] |
1 |
0.0000 |
| 14 |
Protease Inhibitor [EPC] |
1 |
0.0000 |
| 15 |
CD20-directed Cytolytic Antibody [EPC] |
7 |
0.0000 |
| 16 |
Corticosteroid [EPC] |
22 |
0.0000 |
| 17 |
Cytochrome P450 3A Inhibitor [EPC] |
1 |
0.0000 |
| 18 |
Fluoroquinolone Antibacterial [EPC] |
2 |
0.0000 |
| 19 |
Aminosalicylate [EPC] |
1 |
0.0000 |
| 20 |
Proteasome Inhibitor [EPC] |
1 |
0.0000 |
| 21 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
1 |
0.0000 |
| 22 |
Serotonin-3 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 23 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
1 |
0.0000 |
| 24 |
alpha-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 25 |
Azole Antifungal [EPC] |
1 |
0.0000 |
| 26 |
Dihydropyridine Calcium Channel Blocker [EPC] |
2 |
0.0000 |
| 27 |
Kinase Inhibitor [EPC] |
3 |
0.0000 |
| 28 |
Tumor Necrosis Factor Blocker [EPC] |
5 |
0.0000 |
| 29 |
Vitamin C [EPC] |
2 |
0.0000 |
| 30 |
Osmotic Laxative [EPC] |
1 |
0.0000 |
| 31 |
beta-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 32 |
Angiotensin 2 Receptor Blocker [EPC] |
1 |
0.0000 |
| 33 |
HMG-CoA Reductase Inhibitor [EPC] |
1 |
0.0000 |
| 34 |
Benzodiazepine [EPC] |
1 |
0.0000 |
| 35 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
1 |
0.0000 |